The International Longevity Centre Global Alliance (ILC Global Alliance) is an international consortium of member organizations.
The mission of the ILC Global Alliance is to help societies to address longevity and population ageing in positive and productive ways, typically using a life course approach, highlighting older people's productivity and contributions to family and society as a whole. The Alliance member organisations carry out the mission through developing ideas, undertaking research and creating forums for debate and action, in which older people are key stakeholders.
The first International Longevity Centres were established in the United States in 1990 by Robert N. Butler, M.D., and in Japan by Shigeo Morioka, Ex-CEO of Yamanouchi Pharmaceutical Company (current Astellas Pharma Inc.).
The ILC Alliance currently includes centres in the United States of America, Japan, the United Kingdom, France, the Dominican Republic, India, South Africa, Argentina, The Netherlands, Israel, Singapore, Czech Republic, Brazil, China, Germany, Australia and Canada. These centres work both autonomously and collaboratively to study how greater life expectancy and increased proportions of older people impact on nations around the world.
The priorities of the centres are:
To identify productive aging as an important topic, not just paid employment, but also the continuing talent and contributions of older people; and
To promote educational, research and policy initiatives which will advance an active, healthy life throughout the lifecourse.